Vestcor Inc Repligen Corp Transaction History

Vestcor Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$170.78 - $208.42 $2,049 - $2,501	-12 Reduced 0.98%	1,218 $224,000
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $570 - $926	-5 Reduced 0.4%	1,230 $221,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $2,220 - $2,824	-16 Reduced 1.28%	1,235 $196,000
Q4 2022 Feb 15, 2023	BUY	$162.42 - $220.56 $203,187 - $275,920	1,251 New	1,251 $212,000

481

56.3M

251K

458K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.36B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

Stay updated on Vestcor Inc with notifications on news.